Milestone Pharmaceuticals
MIST
MIST
56 hedge funds and large institutions have $96.2M invested in Milestone Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
4.61% less ownership
Funds ownership: 75.07% → 70.47% (-4.6%)
53% less capital invested
Capital invested by funds: $203M → $96.2M (-$107M)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Holders
56
Holding in Top 10
–
Calls
$1.95M
Puts
$468K
Top Buyers
| 1 | +$10.1M | |
| 2 | +$6.84M | |
| 3 | +$4.21M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.46M |
| 5 |
BL
Bleichroeder LP
New York
|
+$3.22M |
Top Sellers
| 1 | -$20.6M | |
| 2 | -$18.4M | |
| 3 | -$10.3M | |
| 4 |
LPC
Lion Point Capital
New York
|
-$7.7M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$6.2M |